Share on StockTwits

athenahealth (NASDAQ:ATHN) Director David Eric Robinson unloaded 30,000 shares of the stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $124.12, for a total transaction of $3,723,600.00. Following the transaction, the director now directly owns 3,692 shares of the company’s stock, valued at approximately $458,251. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Shares of athenahealth (NASDAQ:ATHN) traded down 0.47% during mid-day trading on Thursday, hitting $124.56. The stock had a trading volume of 614,610 shares. athenahealth has a 52 week low of $83.57 and a 52 week high of $206.70. The stock has a 50-day moving average of $121.7 and a 200-day moving average of $145.5. The company’s market cap is $4.713 billion.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings data on Thursday, April 17th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by $0.05. The company had revenue of $163.00 million for the quarter, compared to the consensus estimate of $170.03 million. During the same quarter in the previous year, the company posted $0.38 earnings per share. The company’s revenue for the quarter was up 29.8% on a year-over-year basis. On average, analysts predict that athenahealth will post $1.04 earnings per share for the current fiscal year.

ATHN has been the subject of a number of recent research reports. Analysts at Topeka Capital Markets initiated coverage on shares of athenahealth in a research note on Thursday. They set a “buy” rating on the stock. Separately, analysts at Morgan Stanley reiterated an “overweight” rating on shares of athenahealth in a research note on Monday, May 12th. They now have a $192.00 price target on the stock. Finally, analysts at Oppenheimer cut their price target on shares of athenahealth from $120.00 to $90.00 in a research note on Wednesday, May 7th. They now have an “underperform” rating on the stock. One research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and twelve have issued a buy rating to the company. athenahealth presently has a consensus rating of “Hold” and a consensus target price of $167.84.

athenahealth, Inc (NASDAQ:ATHN), is a business services company, which provides ongoing billing, clinical-related, and other related services to its customers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.